Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients
Molecular Oncology · 2026-08 · 20 (8) · 2040-2053
DOI: 10.1002/1878-0261.70261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 23.04.2026. Verfasst von Yvonne Goy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, Lung Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamburger Krebsgesellschaft, Deutsche Krebshilfe, Erich und Gertrud Roggenbuck-Stiftung.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The response to radiotherapy (RT) is influenced by the individual DNA repair capacity of both the tumor cells and the host. In this study, we assessed whether circulating tumor cell (CTC) enumeration, kinetics, and CTC viability (i.e., the apoptotic rate) could provide a more accurate tool for monitoring and stratifying the RT response. We analyzed CTCs and tumor‐derived extracellular vesicles (tdEVs) during RT in 71 lung ( n = 35) and breast ( n = 36) cancer patients receiving RT treatment for brain ( n = 54) and bone ( n = 19) metastases. The DNA repair capacity of the host was assessed by ex vivo irradiation of peripheral blood mononuclear cells (PBMCs). RT treatment did not seem, in most cases, to cause a short‐term release of CTCs. We found that both the number and apoptotic rate of CTCs before and after RT treatment is a powerful indicator of poor prognosis. Additionally, the fraction of apoptotic CTCs correlated with RT response and patient outcome. This study demonstrated that the RT response is associated with tumor‐specific traits, which can be accessed via easily accessible liquid biopsy approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Tumor Biology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
- Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.
- Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Harriet Wikman
Förderung
- Hamburger Krebsgesellschaft
- Deutsche Krebshilfe
- Erich und Gertrud Roggenbuck-Stiftung
Zitieren
APA
Goy, Y., Löptien, J., Coith, C., Nanou, A., Hintelmann, K., Hans, P., Petersen, C., Pantel, K., Riethdorf, S., Borgmann, K., & Wikman, H. (2026). Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients. Molecular Oncology, 20(8), 2040-2053. https://doi.org/10.1002/1878-0261.70261
Vancouver
Goy Y, Löptien J, Coith C, Nanou A, Hintelmann K, Hans P, et al. Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients. Molecular Oncology. 2026;20(8):2040-2053. doi:10.1002/1878-0261.70261
BibTeX
@article{Goy2026,
author = {Goy, Yvonne and Löptien, Jana and Coith, Cornelia and Nanou, Afroditi and Hintelmann, Katharina and Hans, Pinnschmidt and Petersen, Cordula and Pantel, Klaus and Riethdorf, Sabine and Borgmann, Kerstin and Wikman, Harriet},
title = {Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {8},
pages = {2040--2053},
doi = {10.1002/1878-0261.70261}
}
EUVIMED